4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000950170-24-123538
Chief Scientific Officer sold 8,000 shares at $15.64 ($125,120)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Michaelson Jennifer · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-05 | Sale : show line 1 in the form 10b5-1 | −8,000 | $15.64 | $125,120 | 107,942 | D |
| Open-market sales · 8,000 sh · avg $15.64 · $125,120 | ||||||
Loading xslF345X05/ownership.xml…